Clear Labs Expands Collaboration with Pillar Biosciences to Automate oncoReveal® Myeloid v2 and Essential MPN Panels on the Clear Dx® Platform
Clear Labs extends its fully automated NGS workflows to hematologic malignancy research, helping laboratories bring myeloid and myeloproliferative neoplasm (MPN) profiling in-house with less hands-on time and greater consistency SAN CARLOS, Calif. — November 10, 2026 — Clear Labs, a leader in fully automated next-generation sequencing (NGS) solutions, today announced an expanded collaboration with Pillar […]